bimagrumab glp 1 Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism semaglutide bimagrumab Antibody blockade of

DPP-4 inhibitors: DPP-4 inhibitors work by inhibiting the activity of dipeptidyl peptidase-4 (DPP-4), which reduces the breakdown and inactivation of the incretin GLP-1 (glucagon-like peptide-1), leading to increased endogenous levels of GLP-1

Skip or minimize: rice, cheese, sour cream, queso, and chips

Our promise : No judgment, no BS, just honest medical care from people who understand the job

After spending $120 million on weight-loss drugs in fiscal 2025, the Group Insurance Commission, which provides health insurance to all state employees and retirees, decided it would offer the drugs a new way in 2026

When the body lacks essential minerals and cofactors, it cannot maintain stable energy, mood, or appetite regulation

Organic cation/carnitine transporter, OCTN2, transcriptional activity is regulated by osmotic stress in epididymal cells